RxDoctor Payments Data

Ashley Taylor, PA

Physician Assistant · Yukon, OKNPI 1821313651

Payments from drug & device makers

$2,053in general payments, 2019–2025

Across 110 payments — averaging $18.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$707
  • GSK$176
  • Lilly USA, LLC$154
  • Organon$146
  • Novo Nordisk$142
  • Boehringer Ingelheim$110
  • plus $618 from 22 others

What the payments were for

  • Food & beverage$2,053100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,053 in reported general payments places this provider in the 80th percentile of 1,491 physician assistant providers in Oklahoma.

See all physician assistant providers in Oklahoma

Medicare billing

Part B allowed, 2024
$40,410
Medicare patients
166
Services billed
976

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide68$84,520
OzempicSemaglutide23$29,535
JardianceEmpagliflozin25$22,683
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$12,095
EliquisApixaban14$11,747
FarxigaDapagliflozin Propanediol11$8,444
Breo ElliptaFluticasone/Vilanterol12$5,137
SymbicortBudesonide/Formoterol Fumarate17$3,725
Gabapentin76$1,598
Atorvastatin Calcium88$1,039
Albuterol Sulfate HfaAlbuterol Sulfate46$930
Omeprazole30$914
Levothyroxine Sodium51$718
Trazodone Hcl19$578
Montelukast Sodium31$521

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$154$84,52068 claims
Novo NordiskOzempic$142$29,53523 claims
Boehringer IngelheimJardiance$110$22,68325 claims
GSKTrelegy Ellipta, Breo Ellipta$176$17,23228 claims
AstraZenecaFarxiga, Symbicort$51$12,16928 claims
PfizerEliquis$60$11,74714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,491 physician assistant providers in Oklahoma.

Other physician assistant in Yukon

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →